Published on October 16th, 2014 | by NLS0
GDP for medicinal distribution
The transportation and distribution of temperature sensitive pharmaceutical products is a very important part of the integrated supply chain. By having adequate protocols and controls in place on how the transportation should be handled, the quality and integrity of the products are ensured. The products should maintain the same characteristics and quality as in the factory when they reach the patients. For this reason, the European Commission has published the new “Good Distribution Practice”-guidelines.
The new GDP puts the same temperature control requirements on transportation as on storage of pharmaceutical products. This essentially makes the transportation process a “warehouse on wheels”. This is especially important for refrigerated products (+2 °C to +8 °C) where breaking the cold chain severely damages the sustainability of the pharmaceuticals. Since the correct distribution of medicinal products relies on people, the new guidelines states that all parties involved in the distribution cycle must be trained and attain the proper certificate. As one of the statements, the pharmaceuticals should not be exposed to unacceptable differences in temperature, light and humidity.
Today APS has a complete catalog of package solutions for cold chain transport (+2 °C to +8 °C), room temperature transport (+15 °C to +25 °C) and transport of frozen products (-18 °C/-21 °C) with new solutions being added continuously. All of our package solutions are validated according to the GDP guidelines and offer a well-controlled and even transportation temperature.
Do not hesitate to contact us for more information on how our solutions can help you.
Aircontainer Package System Sweden AB
Tel: +46 (0)8-732 77 32